NF 级胆固醇是VD3 的主要生产原料，目前未有成熟的规模合成工艺，主要通过动物脑髓提取和羊毛脂提取获得，前者工艺相对简单但存在风险，欧美普遍抵制使用，2020 年7 月1 日起国内开始实施VD3 新标准，规定VD3 油起始原料为羊毛脂胆固醇，限制脑干胆固醇在国内的使用。目前全球NF 级胆固醇生产企业主要有花园生物、印度迪氏曼、日本精化、新加坡恩凯四家，新国标的实施有利于保障胆固醇和VD3 产品质量安全，进一步优化行业竞争格局。

COVID-19 is an infectious disease caused by a novel coronavirus. The first ever human encounter of the virus was reported in December 2019 in Wuhan City of China. The virus responsible for the cause of the disease is named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This nomenclature was chosen owing to the fact that the virus is genetically related to a type of coronavirus that was responsible for the SARS outbreak, which occurred in 2003. The report focuses on the products used forCOVID-19 diagnostic such as PCR kits, point of contact (POC) kits, and immunoassay cassettes. In addition, it focuses on technologies used such as PCR and immunoassay. Moreover, it analyzes the current market trends of COVID-19 diagnostics across different regions including North America, Europe, Asia-Pacific, and LAMEA.

The report provides market dynamics and trends related to the global disposable syringes market. In addition, it presents estimations and forecast of the market. It includes revenue generated from the sales of disposable syringes used in vaccination, injecting drugs, and collecting blood samples. For the purpose of analysis, the disposable syringes market size is studied on the basis of product type, application, and region to provide a detailed assessment of the market. On the basis of product type, it is segmented into conventional disposable syringes and safety disposable syringes. By application, it is bifurcated into immunization injections and therapeutic injections. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

Burns are injuries to tissues or skin caused by radiation, heat, friction, chemicals, or electricity. Burn care treatment includes relieving pain, maintaining body fluids & electrolytes, preventing infection, and calorie intake during the healing process. The report provides market dynamics and trends related to the global burn care market. In addition, it presents the estimations and forecast of the market. The valuations comprise revenue generated from burn care products such as advanced burn care, biologics, traditional burn care, and others. The study estimates the revenue generated from the sales of burn care products; however, it excludes the burn care service revenue. Furthermore, the report excludes revenue generated from post-sale services of burn care products.

The report provides market dynamics and trends related to the blood market. It includes revenue generated from the sales of products, which are used to collect and process different components of blood such as source plasma, albumin, and hyperimmune serum. The products which are covered in the report include whole blood collection systems, whole blood collection reagents, source plasma collection systems, source plasma collection reagents, and others. The blood market is segmented into product, end user, and region. On the basis of product, it is classified into whole blood collection and processing, source plasma collection, blood typing products, and blood screening products. Furthermore, all these segments are further classified into sub-segments. For instance, the whole blood collection segment is classified into whole blood collection systems and whole blood collection consumables. The source plasma collection segment is classified into source plasma collection systems and source plasma collection consumables. In addition, the blood typing products are further bifurcated into blood typing systems, blood typing reagents. The blood screening products are divided into blood screening systems, and blood screening reagents.

Blood bank is a place where blood is collected, separated, processed, tested, and stored for future use. In addition, a blood bank provides red blood cells, whole blood, blood plasma, blood platelet and other blood products to the healthcare providers. The report provides market dynamics and trends related to the global blood bank market. In addition, it presents the market estimations and forecast. The study estimates the revenue generated from blood services provided by blood banks such as blood collection, processing, testing, storage, and distribution. A blood banks distributes blood and blood components to hospitals4, ambulatory surgery centers, pharmaceutical companies, clinics & nursing homes, and others. However, the report does not include revenue generated from blood banking devices as well as plasma derivatives and other blood products.

The report provides market dynamics and trends related to the global anti-viral therapies market. In addition, it presents the market estimations and forecast. The study estimates the revenue generated from the sales of the drugs and therapies approved for the treatment of viral infections. The valuations comprise revenue generated from usage of drugs and therapies, in HIV, herpes, hepatitis, and influenza. However, the report does not include revenue generated by dealers, traders, or brokers of the market.

The factors that drive the growth of the anesthesia machinery market include technological advancements in anesthesia monitoring, rise in number of surgical procedures and increase in geriatric population. However, high cost of installation and maintenance and regulatory compliance restrain the growth of the anesthesia machinery market. Furthermore, rise in demand for quality healthcare monitoring and untapped emerging markets are anticipated to provide lucrative opportunities for anesthesia machine manufacturers in the future.

The global Alzheimer ’s disease (AD) diagnostics and therapeutics market is currently composed of five major marketed drugs, donepezil, galantamine, rivastigmine, memantine, and combination of donepezil/memantine; a multitude of brain imaging diagnostics tests; and a highly invasive technique of CSF analysis for AD biomarker identification. The end product/service offered in this market today is the same as what was offered about a decade ago. During the last decade, there were many drugs that made it to the late stages of clinical trials, but almost all of them were rejected for market approval, due to toxicity and safety issues. Today, many drugs are again in the late pipeline stages of drug development for AD. In fact, there are more candidates than ever and there are many novel drug applicants, aimed at addressing the actual pathological cause of AD, which the currently marketed drugs are unable to address. Additionally, the current modality in advanced and late AD diagnosis is composed of brain imaging studies, which sometimes need to be conducted over a wide timespan of months to arrive at the correct diagnosis. The second line of diagnosis is composed of CSF tests, which requires an invasive procedure of lumbar puncture.

Allergy is a condition in which the body immune system reacts abnormally to a foreign substance. The major factors for the growth of the allergy treatment market include the increasing burden of various types of allergies, increased investment by the manufacturers on the development of novel allergic treatments, and rising importance for self-medication. As per the data published by the American College of Allergy, Asthma & Immunology, allergies are the sixth leading cause of chronic illness in the United States, with an annual cost in excess of USD 18 billion, and more than 50 million Americans suffer from allergies each year. Several pharmaceutical companies are focusing even more on global strategies for developing and marketing their products. Therefore, their main goal is to understand the present regulatory situation for allergen products from a worldwide perspective, as this directly affects the availability of these products to patients across the world.